Showing results (21-30 of 6,841) with videos related to

Sort By:
Pageof 685
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2016
Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?-An OverviewLouis P Garrison
Health Care Financing Review|November 6, 2014
Assessment of the effectiveness of supply-side cost-containment measuresLouis P Garrison
Applied Health Economics and Health Policy|June 6, 2022
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based PolicyChris Sampson, Bernarda Zamora, Sam Watson, et al.
Pharmacoepidemiology and Drug Safety|June 4, 2014
Estimating the incremental net health benefit of requirements for cardiovascular risk evaluation for diabetes therapiesAnita J Chawla, Daniel S Mytelka, Stephan D McBride, et al.
Pharmacoeconomics|November 30, 2002
National Institute for Clinical Excellence (NICE): Is economic appraisal working?Adrian Towse, Clive Pritchard
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2019
Uncertainty and Cures: Discontinuation, Irreversibility, and Outcomes-Based Payments: What Is Different About a One-Off Treatment?Adrian Towse, Elisabeth Fenwick
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 14, 2024
It Takes 2 to Tango. Setting Out the Conditions in Which Performance-Based Risk-Sharing Arrangements Work for Both PartiesAdrian Towse, Elisabeth Fenwick
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 5, 2002
The economics of gene therapy and of pharmacogeneticsPatricia Danzon, Adrian Towse
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 18, 2014
Orphan drugs policies: a suitable case for treatmentMichael Drummond, Adrian Towse
Pageof 685